Home Page
Our Services/Products
About GeneThera
GeneThera Research
For the Investor
For The Breeder/Rancher
For The Public
Contact Us
Site Map
Privacy Policy
 
 
 
   
  ON THIS PAGE    Company News
About GeneThera

Investor FAQ's
Our Board of Directors
 
       
  COMPANY NEWS     
       
  ABOUT GENETHERA    GeneThera is an international biotechnology company, dedicated since 1998 to improving food safety by applying the latest molecular technologies to eradicate farm animal disease. The company focuses on developing molecular diagnostic testing and vaccines in the belief that better technology use leads to a better life for all of mankind.

In the U.S., testing has previously only been done on suspected mad cow infected animals who must be killed in order for the testing to be completed. GeneThera’s testing system is designed to analyze a host of individual diseases. The company’s current priorities are Johne;s Disease, Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; and E.Coli 0157:H7 affecting cattle & sheep worldwide.

 
     
 
  INVESTOR FAQ'S    Q. Where is GeneThera, Inc.’s common stock traded?
A. GeneThera, Inc. is a fully reporting company trading on the electronic NASDAQ     Pink Sheets, under the ticker symbol “GTHR.PK”.

Q. Under what industry is GeneThera, Inc.’s categorized?
A. GeneThera, Inc. operates in the life science and technology sectors of the     Biotechnology industry.

Q. What year was GeneThera, Inc. incorporated?
A. GeneThera, Inc. was incorporated in Colorado in 1998.

Q. When was GeneThera, Inc.’s reversed merger?
A. The reversed merger was with Hand Brand Distribution, Inc. in April 2003.

Q. Who is GeneThera, Inc.’s transfer agent?
A. GeneThera, Inc.’s transfer agent is GTI Corporate Transfer Agents, LLC; 7577     W. 103rd. Ave., Ste 209 Westminster, CO 80021.
    Phone number: 303-466-1216
    E-mail: gticta@live.com

Q. What is the company’s CUSIP number?
A. The CUSIP number of GeneThera, Inc.’s common stock is 37185 E 207.

Q. Does GeneThera, Inc. pay a common stock dividend?
A. No

Q. When does GeneThera, Inc. release earnings?
A. GeneThera, Inc. reports earnings on a quarterly basis. The time and date of all
    future earnings announcements will be posted on the company’s website.

Q. When is GeneThera, Inc.’s Annual Shareholders’ Meeting?
A. GeneThera, Inc.’s next annual shareholders’ meeting will take place on July 26,
    2010 in Arvada, Colorado.

Q. Who are GeneThera, Inc.’s independent accountants?
A. GeneThera, Inc.’s independent accountants are Malone Bailey, PC.

Q. When is GeneThera, Inc.’s fiscal year end?
A. Our fiscal year will end on the Friday nearest to December 31st.

Q. Where is GeneThera, Inc.’s headquarters?
A. GeneThera, Inc.’s headquarters are located in Arvada, CO.

 
     
 
  OUR BOARD OF  DIRECTORS   

Dr. Tony Milici—Chairman of the Board, CEO
Dr. Milici is a Ph.D. in Experimental Hematology and M.D. in Medicine and Surgery, receiving degrees from University of Rome (Italy) and Stanford University. His specialties include: molecular biology/biotechnology, Gene Therapy/Molecularly Oncology and Molecular. He has had extensive post-graduate training that includes a fellowship in the Department of Clinical Immunology with the University of Texas M.D. Anderson Cancer Center and Visiting Fellow at University of Rome's Laboratory of Cellular Immunology and Biochemistry. Among his post-graduate activities, Dr. Milici was an Assistant Professor at the Medical College of Georgia's Department of Pharmacology & Toxology as well as an Assistant Biochemist in the Department of Molecular Pathology at the University of Texas M.D. Anderson Cancer Center in Houston, TX. Prior to founding GeneThera, Inc., Dr. Milici was President & CEO of Genetrans, Inc. based in Augusta, GA., a diagnostics laboratory. For Dr. Milici, GeneThera is a realization of an ambition to demonstrate the commercial potential of molecular biotechnology.

 


 

 
         
BACK TO TOP | Home Page | Our Services/Products | About GeneThera
GeneThera Research
| For The Breeder/Rancher | For The Public | Contact Us | Site Map | Privacy Policy